JP7385256B2 - Oral composition - Google Patents
Oral composition Download PDFInfo
- Publication number
- JP7385256B2 JP7385256B2 JP2019193034A JP2019193034A JP7385256B2 JP 7385256 B2 JP7385256 B2 JP 7385256B2 JP 2019193034 A JP2019193034 A JP 2019193034A JP 2019193034 A JP2019193034 A JP 2019193034A JP 7385256 B2 JP7385256 B2 JP 7385256B2
- Authority
- JP
- Japan
- Prior art keywords
- kale
- vitamin
- present
- powder
- protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000203 mixture Substances 0.000 title claims description 65
- 235000012905 Brassica oleracea var viridis Nutrition 0.000 claims description 86
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 claims description 85
- 240000007124 Brassica oleracea Species 0.000 claims description 82
- 239000000843 powder Substances 0.000 claims description 44
- 235000018102 proteins Nutrition 0.000 claims description 27
- 108090000623 proteins and genes Proteins 0.000 claims description 27
- 102000004169 proteins and genes Human genes 0.000 claims description 27
- 235000008708 Morus alba Nutrition 0.000 claims description 24
- 240000000249 Morus alba Species 0.000 claims description 24
- 239000000284 extract Substances 0.000 claims description 21
- 239000004376 Sucralose Substances 0.000 claims description 20
- 235000019408 sucralose Nutrition 0.000 claims description 20
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 claims description 20
- 239000004615 ingredient Substances 0.000 claims description 10
- 210000003205 muscle Anatomy 0.000 claims description 9
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 6
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims description 4
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 3
- 244000068988 Glycine max Species 0.000 claims description 3
- 235000010469 Glycine max Nutrition 0.000 claims description 3
- 229930003268 Vitamin C Natural products 0.000 claims description 3
- 235000013336 milk Nutrition 0.000 claims description 3
- 239000008267 milk Substances 0.000 claims description 3
- 210000004080 milk Anatomy 0.000 claims description 3
- 235000019154 vitamin C Nutrition 0.000 claims description 3
- 239000011718 vitamin C Substances 0.000 claims description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 2
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims description 2
- 108010046377 Whey Proteins Proteins 0.000 claims description 2
- 102000007544 Whey Proteins Human genes 0.000 claims description 2
- 239000011575 calcium Substances 0.000 claims description 2
- 229910052791 calcium Inorganic materials 0.000 claims description 2
- 239000006071 cream Substances 0.000 claims description 2
- 230000002708 enhancing effect Effects 0.000 claims description 2
- 229960000304 folic acid Drugs 0.000 claims description 2
- 235000019152 folic acid Nutrition 0.000 claims description 2
- 239000011724 folic acid Substances 0.000 claims description 2
- 235000019155 vitamin A Nutrition 0.000 claims description 2
- 239000011719 vitamin A Substances 0.000 claims description 2
- 235000010374 vitamin B1 Nutrition 0.000 claims description 2
- 239000011691 vitamin B1 Substances 0.000 claims description 2
- 235000021119 whey protein Nutrition 0.000 claims description 2
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 claims 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims 1
- PVXPPJIGRGXGCY-DJHAAKORSA-N 6-O-alpha-D-glucopyranosyl-alpha-D-fructofuranose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@](O)(CO)O1 PVXPPJIGRGXGCY-DJHAAKORSA-N 0.000 claims 1
- WBZFUFAFFUEMEI-UHFFFAOYSA-M Acesulfame k Chemical compound [K+].CC1=CC(=O)[N-]S(=O)(=O)O1 WBZFUFAFFUEMEI-UHFFFAOYSA-M 0.000 claims 1
- 240000007087 Apium graveolens Species 0.000 claims 1
- 235000015849 Apium graveolens Dulce Group Nutrition 0.000 claims 1
- 235000010591 Appio Nutrition 0.000 claims 1
- 235000003261 Artemisia vulgaris Nutrition 0.000 claims 1
- 240000006891 Artemisia vulgaris Species 0.000 claims 1
- 235000000832 Ayote Nutrition 0.000 claims 1
- 241000894006 Bacteria Species 0.000 claims 1
- 235000011299 Brassica oleracea var botrytis Nutrition 0.000 claims 1
- 235000017647 Brassica oleracea var italica Nutrition 0.000 claims 1
- 240000003259 Brassica oleracea var. botrytis Species 0.000 claims 1
- 235000010149 Brassica rapa subsp chinensis Nutrition 0.000 claims 1
- 244000221633 Brassica rapa subsp chinensis Species 0.000 claims 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims 1
- 240000004244 Cucurbita moschata Species 0.000 claims 1
- 235000009854 Cucurbita moschata Nutrition 0.000 claims 1
- 235000009804 Cucurbita pepo subsp pepo Nutrition 0.000 claims 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 claims 1
- 244000000626 Daucus carota Species 0.000 claims 1
- 235000002767 Daucus carota Nutrition 0.000 claims 1
- VTLYFUHAOXGGBS-UHFFFAOYSA-N Fe3+ Chemical compound [Fe+3] VTLYFUHAOXGGBS-UHFFFAOYSA-N 0.000 claims 1
- 240000005979 Hordeum vulgare Species 0.000 claims 1
- 235000007340 Hordeum vulgare Nutrition 0.000 claims 1
- 241001299819 Hordeum vulgare subsp. spontaneum Species 0.000 claims 1
- 229920001202 Inulin Polymers 0.000 claims 1
- 235000007688 Lycopersicon esculentum Nutrition 0.000 claims 1
- 244000302512 Momordica charantia Species 0.000 claims 1
- 235000009811 Momordica charantia Nutrition 0.000 claims 1
- 240000008790 Musa x paradisiaca Species 0.000 claims 1
- 235000018290 Musa x paradisiaca Nutrition 0.000 claims 1
- 240000009164 Petroselinum crispum Species 0.000 claims 1
- 244000090599 Plantago psyllium Species 0.000 claims 1
- 235000010451 Plantago psyllium Nutrition 0.000 claims 1
- 241001092473 Quillaja Species 0.000 claims 1
- 235000009001 Quillaja saponaria Nutrition 0.000 claims 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims 1
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 claims 1
- 240000003768 Solanum lycopersicum Species 0.000 claims 1
- 235000009337 Spinacia oleracea Nutrition 0.000 claims 1
- 244000300264 Spinacia oleracea Species 0.000 claims 1
- 235000021307 Triticum Nutrition 0.000 claims 1
- 244000098338 Triticum aestivum Species 0.000 claims 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims 1
- 229930003451 Vitamin B1 Natural products 0.000 claims 1
- 229930003779 Vitamin B12 Natural products 0.000 claims 1
- 229930003471 Vitamin B2 Natural products 0.000 claims 1
- 229930003316 Vitamin D Natural products 0.000 claims 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims 1
- 229930003427 Vitamin E Natural products 0.000 claims 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims 1
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 claims 1
- 239000000619 acesulfame-K Substances 0.000 claims 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims 1
- 235000015197 apple juice Nutrition 0.000 claims 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 claims 1
- 229960002079 calcium pantothenate Drugs 0.000 claims 1
- 235000013339 cereals Nutrition 0.000 claims 1
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 claims 1
- 229910052802 copper Inorganic materials 0.000 claims 1
- 239000010949 copper Substances 0.000 claims 1
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 claims 1
- 235000011180 diphosphates Nutrition 0.000 claims 1
- 235000021323 fish oil Nutrition 0.000 claims 1
- 235000003599 food sweetener Nutrition 0.000 claims 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims 1
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims 1
- 229940029339 inulin Drugs 0.000 claims 1
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 claims 1
- 239000004310 lactic acid Substances 0.000 claims 1
- 235000014655 lactic acid Nutrition 0.000 claims 1
- 239000000395 magnesium oxide Substances 0.000 claims 1
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 claims 1
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 claims 1
- 150000004667 medium chain fatty acids Chemical class 0.000 claims 1
- 235000011197 perejil Nutrition 0.000 claims 1
- 239000001508 potassium citrate Substances 0.000 claims 1
- QEEAPRPFLLJWCF-UHFFFAOYSA-K potassium citrate (anhydrous) Chemical compound [K+].[K+].[K+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O QEEAPRPFLLJWCF-UHFFFAOYSA-K 0.000 claims 1
- 235000015136 pumpkin Nutrition 0.000 claims 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 claims 1
- 229940048084 pyrophosphate Drugs 0.000 claims 1
- 229960002477 riboflavin Drugs 0.000 claims 1
- 235000013570 smoothie Nutrition 0.000 claims 1
- 239000001509 sodium citrate Substances 0.000 claims 1
- 239000003765 sweetening agent Substances 0.000 claims 1
- 229960003495 thiamine Drugs 0.000 claims 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 claims 1
- 239000002562 thickening agent Substances 0.000 claims 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 claims 1
- 235000015870 tripotassium citrate Nutrition 0.000 claims 1
- HRXKRNGNAMMEHJ-UHFFFAOYSA-K trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 claims 1
- 229940038773 trisodium citrate Drugs 0.000 claims 1
- 235000019163 vitamin B12 Nutrition 0.000 claims 1
- 239000011715 vitamin B12 Substances 0.000 claims 1
- 235000019164 vitamin B2 Nutrition 0.000 claims 1
- 239000011716 vitamin B2 Substances 0.000 claims 1
- 235000019158 vitamin B6 Nutrition 0.000 claims 1
- 239000011726 vitamin B6 Substances 0.000 claims 1
- 235000019166 vitamin D Nutrition 0.000 claims 1
- 239000011710 vitamin D Substances 0.000 claims 1
- 150000003710 vitamin D derivatives Chemical class 0.000 claims 1
- 235000019165 vitamin E Nutrition 0.000 claims 1
- 239000011709 vitamin E Substances 0.000 claims 1
- 229940046009 vitamin E Drugs 0.000 claims 1
- 229940045997 vitamin a Drugs 0.000 claims 1
- 229940011671 vitamin b6 Drugs 0.000 claims 1
- 229940046008 vitamin d Drugs 0.000 claims 1
- 239000000230 xanthan gum Substances 0.000 claims 1
- 229920001285 xanthan gum Polymers 0.000 claims 1
- 229940082509 xanthan gum Drugs 0.000 claims 1
- 235000010493 xanthan gum Nutrition 0.000 claims 1
- 239000011701 zinc Substances 0.000 claims 1
- 229910052725 zinc Inorganic materials 0.000 claims 1
- 239000000463 material Substances 0.000 description 39
- 239000000047 product Substances 0.000 description 33
- 241000208251 Gymnema Species 0.000 description 22
- 230000000694 effects Effects 0.000 description 22
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 18
- 238000012360 testing method Methods 0.000 description 17
- 239000006185 dispersion Substances 0.000 description 14
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 12
- 210000003098 myoblast Anatomy 0.000 description 11
- 238000002156 mixing Methods 0.000 description 10
- 230000037228 dieting effect Effects 0.000 description 9
- 230000035755 proliferation Effects 0.000 description 9
- 235000001916 dieting Nutrition 0.000 description 8
- 239000002994 raw material Substances 0.000 description 8
- 239000002904 solvent Substances 0.000 description 8
- 241000196324 Embryophyta Species 0.000 description 7
- 239000007788 liquid Substances 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- 235000013361 beverage Nutrition 0.000 description 6
- 230000036541 health Effects 0.000 description 6
- 235000013402 health food Nutrition 0.000 description 6
- 230000006872 improvement Effects 0.000 description 6
- 239000002245 particle Substances 0.000 description 6
- 244000064816 Brassica oleracea var. acephala Species 0.000 description 5
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 5
- 241000543810 Sasa veitchii Species 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 4
- 108010073771 Soybean Proteins Proteins 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 230000001965 increasing effect Effects 0.000 description 4
- 238000010298 pulverizing process Methods 0.000 description 4
- 229940001941 soy protein Drugs 0.000 description 4
- 229930003231 vitamin Natural products 0.000 description 4
- 235000013343 vitamin Nutrition 0.000 description 4
- 239000011782 vitamin Substances 0.000 description 4
- 229940088594 vitamin Drugs 0.000 description 4
- 238000002835 absorbance Methods 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- 210000000577 adipose tissue Anatomy 0.000 description 3
- 230000004663 cell proliferation Effects 0.000 description 3
- 235000005911 diet Nutrition 0.000 description 3
- 230000037213 diet Effects 0.000 description 3
- 239000008187 granular material Substances 0.000 description 3
- 238000000227 grinding Methods 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 238000005728 strengthening Methods 0.000 description 3
- 239000003826 tablet Substances 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- 241000208253 Gymnema sylvestre Species 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 240000008415 Lactuca sativa Species 0.000 description 2
- 235000003228 Lactuca sativa Nutrition 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 230000003579 anti-obesity Effects 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003925 fat Substances 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- 235000013373 food additive Nutrition 0.000 description 2
- 239000002778 food additive Substances 0.000 description 2
- 235000013376 functional food Nutrition 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 238000004806 packaging method and process Methods 0.000 description 2
- 235000019629 palatability Nutrition 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- 239000001100 (2S)-5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)chroman-4-one Substances 0.000 description 1
- YVHUUEPYEDOELM-UHFFFAOYSA-N 2-ethylpropanedioic acid;piperidin-1-id-2-ylmethylazanide;platinum(2+) Chemical compound [Pt+2].[NH-]CC1CCCC[N-]1.CCC(C(O)=O)C(O)=O YVHUUEPYEDOELM-UHFFFAOYSA-N 0.000 description 1
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 1
- IBFXLTFIVWRUQC-OVGYCKTGSA-N 9b,10b-epoxyroridin d Chemical compound C([C@@]12[C@]3(C)[C@H]4C[C@H]1OC1C5OC5(C)CCC13COC(=O)C1O[C@@]1(C)CCOC(\C=C\C=C/C(=O)O4)C(O)C)O2 IBFXLTFIVWRUQC-OVGYCKTGSA-N 0.000 description 1
- 240000002234 Allium sativum Species 0.000 description 1
- 241000208327 Apocynaceae Species 0.000 description 1
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 description 1
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 description 1
- 235000004222 Brassica oleracea var ramosa Nutrition 0.000 description 1
- 235000001138 Brassica oleracea var. palmifolia Nutrition 0.000 description 1
- 240000002000 Brassica oleracea var. ramosa Species 0.000 description 1
- 102000011632 Caseins Human genes 0.000 description 1
- 108010076119 Caseins Proteins 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- QUQPHWDTPGMPEX-UHFFFAOYSA-N Hesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(COC4C(C(O)C(O)C(C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-UHFFFAOYSA-N 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- 241000134253 Lanka Species 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 235000000060 Malva neglecta Nutrition 0.000 description 1
- 240000000982 Malva neglecta Species 0.000 description 1
- 241000218231 Moraceae Species 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 108010084695 Pea Proteins Proteins 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 241000209504 Poaceae Species 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 238000003916 acid precipitation Methods 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 238000005054 agglomeration Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- QUQPHWDTPGMPEX-UTWYECKDSA-N aurantiamarin Natural products COc1ccc(cc1O)[C@H]1CC(=O)c2c(O)cc(O[C@@H]3O[C@H](CO[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O)[C@@H](O)[C@H](O)[C@H]3O)cc2O1 QUQPHWDTPGMPEX-UTWYECKDSA-N 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 239000007894 caplet Substances 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- 229930002875 chlorophyll Natural products 0.000 description 1
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- APSNPMVGBGZYAJ-GLOOOPAXSA-N clematine Natural products COc1cc(ccc1O)[C@@H]2CC(=O)c3c(O)cc(O[C@@H]4O[C@H](CO[C@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)cc3O2 APSNPMVGBGZYAJ-GLOOOPAXSA-N 0.000 description 1
- 230000009194 climbing Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 125000004387 flavanoid group Chemical group 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 235000004611 garlic Nutrition 0.000 description 1
- 229930183009 gymnemic acid Natural products 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 229940025878 hesperidin Drugs 0.000 description 1
- VUYDGVRIQRPHFX-UHFFFAOYSA-N hesperidin Natural products COc1cc(ccc1O)C2CC(=O)c3c(O)cc(OC4OC(COC5OC(O)C(O)C(O)C5O)C(O)C(O)C4O)cc3O2 VUYDGVRIQRPHFX-UHFFFAOYSA-N 0.000 description 1
- QUQPHWDTPGMPEX-QJBIFVCTSA-N hesperidin Chemical compound C1=C(O)C(OC)=CC=C1[C@H]1OC2=CC(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]4[C@@H]([C@H](O)[C@@H](O)[C@H](C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-QJBIFVCTSA-N 0.000 description 1
- 239000008123 high-intensity sweetener Substances 0.000 description 1
- 239000000399 hydroalcoholic extract Substances 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000037323 metabolic rate Effects 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- ARGKVCXINMKCAZ-UHFFFAOYSA-N neohesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(CO)O3)OC3C(C(O)C(O)C(C)O3)O)=CC(O)=C2C(=O)C1 ARGKVCXINMKCAZ-UHFFFAOYSA-N 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 235000013615 non-nutritive sweetener Nutrition 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 235000019702 pea protein Nutrition 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 235000021118 plant-derived protein Nutrition 0.000 description 1
- 239000012254 powdered material Substances 0.000 description 1
- 238000011533 pre-incubation Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- -1 rounds Substances 0.000 description 1
- IKGXIBQEEMLURG-NVPNHPEKSA-N rutin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-NVPNHPEKSA-N 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 230000035936 sexual power Effects 0.000 description 1
- 235000013322 soy milk Nutrition 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000030968 tissue homeostasis Effects 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 235000019871 vegetable fat Nutrition 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Images
Description
本発明は、ケールを含有する経口組成物に関する。 The present invention relates to oral compositions containing kale.
近年、健康に対する関心の高まり等を背景に、種々の健康食品の開発が行われており、健康食品に用いられる様々な素材の研究が行われている。 In recent years, against the background of increasing interest in health, various health foods have been developed, and various materials used in health foods are being researched.
例えば、ケールは、キャベツなどと同じアブラナ科植物の1種であり、ビタミンCなどのビタミン類、ミネラル類、食物繊維、クロロフィルなどに富み、また、胃炎や胃潰瘍の予防、肝機能の改善や便秘に有効であるなど、人体の健康維持に適する健康素材として注目を浴びている(例えば、特許文献1参照)。 For example, kale is a member of the cruciferous family like cabbage, and is rich in vitamins such as vitamin C, minerals, dietary fiber, and chlorophyll, and is also useful for preventing gastritis and stomach ulcers, improving liver function, and constipation. It is attracting attention as a health material suitable for maintaining the health of the human body, such as being effective for the health of the human body (see, for example, Patent Document 1).
また、健康志向と同様に安全志向の高い昨今では、日常的に食されているケールのような安全な素材を用いたものが好まれ、このような食経験のあるケールが有する有用な機能をより活用することが望まれている。 In addition, these days, people are as conscious about safety as they are about health, and people prefer foods made from safe ingredients like kale, which is eaten on a daily basis. It is hoped that they will be utilized more.
本発明の課題は、筋肉組織の維持・増強作用を有するケール含有経口組成物を提供することにある。 An object of the present invention is to provide a kale-containing oral composition that has the effect of maintaining and enhancing muscle tissue.
本発明者らは、ケールと共に、特定の素材(他素材)を用いることにより、優れた筋芽細胞の増殖作用が得られることを見いだし、本発明を完成するに至った。 The present inventors have discovered that an excellent myoblast proliferation effect can be obtained by using a specific material (other materials) together with kale, and have completed the present invention.
すなわち、本発明は、以下のとおりのものである。
[1]ケールと、プロテイン、ギムネマ、スクラロース、桑及びクマザサから選ばれる少なくとも1種の他素材とを含有することを特徴とする経口組成物。
[2]少なくとも2種の他素材を含有することを特徴とする上記[1]記載の経口組成物。
[3]ダイエットのために用いられることを特徴とする上記[1]又は[2]記載の経口組成物。
[4]ケールの乾燥粉末を含むことを特徴とする上記[1]~[3]のいずれか記載の経口組成物。
[5]ケールの乾燥粉末が、ケールの乾燥緑葉を粉砕し粉末化した乾燥粉末であることを特徴とする上記[4]記載の経口組成物。
That is, the present invention is as follows.
[1] An oral composition containing kale and at least one other material selected from protein, gymnema, sucralose, mulberry, and kumama.
[2] The oral composition according to [1] above, which contains at least two other materials.
[3] The oral composition according to [1] or [2] above, which is used for dieting.
[4] The oral composition according to any one of [1] to [3] above, which comprises dry powder of kale.
[5] The oral composition according to [4] above, wherein the dry powder of kale is a dry powder obtained by crushing and powdering dry green leaves of kale.
本発明の経口組成物は、優れた筋肉組織の維持・増強作用を有する。 The oral composition of the present invention has excellent muscle tissue maintenance and strengthening effects.
本発明の経口組成物は、ケールと、プロテイン、ギムネマ、スクラロース、桑及びクマザサから選ばれる少なくとも1種の他素材とを含有することを特徴とする。 The oral composition of the present invention is characterized by containing kale and at least one other material selected from protein, gymnema, sucralose, mulberry, and kumamaza.
本発明の経口組成物は、優れた筋芽細胞の増殖作用を有し、筋肉組織の維持・増強を図ることができる。また、筋肉組織はエネルギー代謝が活発な組織であるため、この筋肉組織の維持・増強が図られることにより基礎代謝量が維持・増加し、ひいては肥満予防及び/又は解消作用によるダイエット効果を得ることができる。 The oral composition of the present invention has an excellent myoblast proliferation effect and can maintain and strengthen muscle tissue. In addition, since muscle tissue is a tissue that actively metabolizes energy, by maintaining and strengthening this muscle tissue, basal metabolic rate can be maintained and increased, and in turn, a diet effect can be obtained by preventing and/or eliminating obesity. Can be done.
また、本発明のケール及び少なくとも1種以上の他素材を含む経口組成物は、ケール単独に比して高い分散性を有する。すなわち、本発明の経口組成物は、凝集しにくい粉体(粉末)である。この分散性の高い経口組成物は、単に混合するだけで調製できるものであり、その調製も容易である。例えば、凝集性が強く、塊を形成しやすい原料を混合する際には、その原料について粉砕機を用いた解砕等の前処理を行い、原料の流動性を確保したうえで仕込み、さらに、仕込み後は、再凝集しないようできるだけ速やかに給気し、流動を開始する必要があることが知られているが、このような煩雑な操作を行う必要がない。また、凝集性が強く、塊を形成しやすい原料と賦形剤を予め混合することで付着性を緩和できる場合があることも知られているが、このような添加も必要ない。 Furthermore, the oral composition containing the kale of the present invention and at least one other material has higher dispersibility than kale alone. That is, the oral composition of the present invention is a powder that does not easily aggregate. This highly dispersible oral composition can be prepared simply by mixing, and is easy to prepare. For example, when mixing raw materials that are highly cohesive and tend to form lumps, the raw materials are pretreated such as crushing using a crusher to ensure fluidity of the raw materials before being mixed. It is known that after charging, it is necessary to supply air and start flow as quickly as possible to prevent reagglomeration, but there is no need to perform such complicated operations. It is also known that adhesion can sometimes be alleviated by pre-mixing excipients with raw materials that are highly cohesive and tend to form lumps, but such addition is not necessary.
また、ケール及び少なくとも1種以上の他素材を含む本発明の組成物は分散性が高いことから、さらにケール及び他素材以外の素材を混合して本発明の経口組成物とする場合にも、上記のような煩雑な操作を行う必要がなく、単に混合するだけで調製することができる。 Furthermore, since the composition of the present invention containing kale and at least one other material has high dispersibility, even when materials other than kale and other materials are mixed to form the oral composition of the present invention, There is no need to perform complicated operations such as those described above, and the preparation can be performed simply by mixing.
[ケール]
ケールは、アブラナ科植物である。本発明において用いるケールの品種は特に制限されるものではなく、キッチンケール、ツリーケール、ブッシュケール、マローケール、コラード、緑葉カンラン等の様々な種類のケールを用いることができる。ケールは、収穫後、直ちに乾燥、粉砕等の加工処理を施したものであることが好ましい。処理までに時間を要する場合には、ケールの変質を防ぐために低温貯蔵などの当業者が通常用いる貯蔵手段により貯蔵することが好ましい。本発明において用いる部位としては、葉が好ましく、葉の中でも緑葉が好ましい。また、葉と共に茎を含んでいてもよい。
[Kale]
Kale is a plant in the cruciferous family. The variety of kale used in the present invention is not particularly limited, and various types of kale such as kitchen kale, tree kale, bush kale, mallow kale, collard, and green-leafed kale can be used. It is preferable that the kale be processed immediately after harvesting, such as drying and pulverizing. If it takes time to process, it is preferable to store the kale by storage means commonly used by those skilled in the art, such as low temperature storage, to prevent deterioration of the quality of the kale. The site used in the present invention is preferably a leaf, and among leaves, green leaves are preferred. Moreover, the stem may be included together with the leaves.
ケールは、粉砕物、搾汁、抽出物等として用いることができる。粉砕物としては、乾燥粉末、細片化物及びその乾燥物(乾燥細片化物)等を挙げることができる。搾汁や抽出物は、液状であってもよいが、ペースト状や乾燥粉末(搾汁末、エキス末)として用いることもできる。抽出物は、適当な溶媒を用いて抽出することで得ることができ、溶媒としては、例えば、水(温水、熱水)、エタノール、含水エタノールを用いることができる。ケールは、ケールの含有する栄養成分を有効に活用できることから、ケールの乾燥緑葉が好ましく、細片化物及びその乾燥物(乾燥細片化物)がより好ましく、粉砕し粉末化した乾燥粉末であることが特に好ましい。また、ケールの乾燥粉末は、粒径75μm以下のものが60%以上であることが好ましく、75%以上であることがより好ましく、90%以上であることが特に好ましい。 Kale can be used as a crushed product, juice, extract, etc. Examples of the pulverized product include a dry powder, a finely divided product, and a dried product thereof (dried finely divided product). The squeezed juice or extract may be in liquid form, but it can also be used in the form of a paste or dry powder (squeezed juice powder, extract powder). The extract can be obtained by extraction using an appropriate solvent, and examples of the solvent that can be used include water (warm water, hot water), ethanol, and aqueous ethanol. As for kale, since the nutritional components contained in kale can be effectively utilized, dried green leaves of kale are preferable, and fragmented products and dried products thereof (dried fragmented products) are more preferable, and dry powder obtained by pulverizing and pulverizing. is particularly preferred. Moreover, it is preferable that the dry powder of kale has a particle size of 75 μm or less in a proportion of 60% or more, more preferably 75% or more, and particularly preferably 90% or more.
[他素材]
ケールと共に用いられる他素材は、プロテイン、ギムネマ、スクラロース、桑及びクマザサから選ばれる少なくとも1種であり、これらの他素材を少なくとも2種組み合わせて用いることが好ましい。他素材を2種以上組み合わせる場合、プロテイン及び桑の組合せ、又はギムネマ及びスクラロースの組合せが特に好ましい。すなわち、ケール、プロテイン及び桑を含む経口組成物、並びにケール、ギムネマ及びスクラロースを含む経口組成物は、その組合せの相乗的な作用により、特に優れた筋芽細胞の増殖作用を発揮することから好ましく、特に優れたダイエット(抗肥満)効果を期待することができる。
[Other materials]
The other material used together with kale is at least one selected from protein, gymnema, sucralose, mulberry, and kumama, and it is preferable to use a combination of at least two of these other materials. When combining two or more other materials, a combination of protein and mulberry, or a combination of gymnema and sucralose is particularly preferred. That is, oral compositions containing kale, protein, and mulberry, and oral compositions containing kale, gymnema, and sucralose are preferred because they exhibit particularly excellent myoblast proliferation effects due to the synergistic action of the combination. , particularly excellent diet (anti-obesity) effects can be expected.
(プロテイン)
プロテインは、動物や植物に含まれるタンパク質を抽出・精製したものであり、市販品を用いることができる。本発明においては、粉末状のものが好ましい。動物由来のプロテインとしては、例えば、ホエイプロテイン、カゼインプロテイン、エッグプロテイン、ビーフプロテイン等を挙げることができ、植物由来のプロテインとしては、例えば、ソイプロテイン、ピープロテイン、ライスプロテイン等を挙げることができる。本発明においては、植物由来のプロテインを用いることが好ましく、ケールと組み合わせることで、特に優れた筋芽細胞の増殖作用を発揮することから、中でも、大豆由来のプロテイン(ソイプロテイン)を用いることがより好ましい。また、ケールと組み合わせることで、特に優れた分散性向上作用を発揮することから、ソイプロテインは乾物換算でタンパク質含量が50%以上のものが好ましく、70%以上のものが好ましく、90%以上のものが特に好ましい。
(protein)
Protein is extracted and purified protein contained in animals and plants, and commercially available products can be used. In the present invention, powdered materials are preferred. Examples of animal-derived proteins include whey protein, casein protein, egg protein, beef protein, etc.; examples of plant-derived proteins include soy protein, pea protein, rice protein, etc. . In the present invention, it is preferable to use protein derived from plants, and it is particularly preferable to use protein derived from soybeans (soy protein) because it exhibits a particularly excellent myoblast proliferation effect when combined with kale. More preferred. In addition, soy protein has a protein content of preferably 50% or more, preferably 70% or more, and 90% or more in terms of dry matter, since it exhibits a particularly excellent dispersibility-improving effect when combined with kale. Particularly preferred.
(ギムネマ)
ギムネマは、インドやスリランカを原産とするキョウチクトウ科に属する蔓性植物であり、例えば、Gymnema sylvestre(ギムネマシルベスタ)を挙げることができる。本発明において用いる部位としては、葉が好ましい。また、葉と共に茎を含んでいてもよい。ギムネマは、粉砕物、搾汁、抽出物等として用いることができる。粉砕物としては、乾燥粉末、細片化物及びその乾燥物(乾燥細片化物)等が挙げられる。搾汁や抽出物は、液状であってもよいが、ペースト状や乾燥粉末(搾汁末、エキス末)として用いることもできる。抽出物は、適当な溶媒を用いて抽出することにより得ることができ、溶媒としては、例えば、水(熱水)、エタノール、含水エタノールを用いることができる。本発明においては、ギムネマの乾燥粉末が好ましく、ケールと組み合わせることで、特に優れた筋芽細胞の増殖作用を発揮することから、ギムネマの葉の含水アルコール抽出物の乾燥粉末を用いることがより好ましい。また、ギムネマの葉の乾燥粉末は、ケールと組み合わせることで、特に優れた分散性向上作用を発揮することから、ギムネマ酸含量が5~80%であることが好ましく、10~60%であることがより好ましく、20~40%であることが特に好ましい。
(gymnema)
Gymnema is a climbing plant that belongs to the Apocynaceae family and is native to India and Sri Lanka, such as Gymnema sylvestre. As the site used in the present invention, leaves are preferred. Moreover, the stem may be included together with the leaves. Gymnema can be used as a ground product, squeezed product, extract, etc. Examples of the pulverized product include a dry powder, a finely divided product, and a dried product thereof (dried finely divided product). The squeezed juice or extract may be in liquid form, but it can also be used in the form of a paste or dry powder (squeezed juice powder, extract powder). The extract can be obtained by extraction using an appropriate solvent, and examples of the solvent that can be used include water (hot water), ethanol, and aqueous ethanol. In the present invention, dry powder of Gymnema is preferable, and it is more preferable to use a dry powder of hydroalcoholic extract of Gymnema leaves because it exhibits a particularly excellent myoblast proliferation effect when combined with kale. . In addition, since the dried powder of gymnema leaves exhibits a particularly excellent dispersibility improving effect when combined with kale, the gymnematic acid content is preferably 5 to 80%, and preferably 10 to 60%. is more preferable, and particularly preferably 20 to 40%.
(スクラロース)
スクラロースは、蔗糖を原料として製造され、蔗糖の約600倍の甘味度を有する安全性の高いノンカロリー高甘味度甘味料である。本発明においては、液状、粉末状、固体状等の各種形態のものを用いることができ、市販品を用いることができる。本発明においては、粉末状のものが好ましく、ケールと組み合わせることで、特に優れた分散性向上作用を発揮することから、粒径は20メッシュ以下のものが80%以上であることが好ましく、90%以上であることがより好ましく、99%以上であることが特に好ましい。
(Sucralose)
Sucralose is a highly safe, non-caloric, high-intensity sweetener that is manufactured from sucrose and has a sweetness approximately 600 times that of sucrose. In the present invention, various forms such as liquid, powder, and solid can be used, and commercially available products can be used. In the present invention, a powder is preferable, and when combined with kale, it exhibits a particularly excellent effect of improving dispersibility. Therefore, it is preferable that 80% or more of the particle size is 20 mesh or less, and 90 % or more, and particularly preferably 99% or more.
(桑)
桑は、クワ科植物である。本発明において用いる部位としては、葉が好ましく、葉の中でも緑葉が好ましい。また、葉と共に茎を含んでいてもよい。桑は、粉砕物、搾汁、抽出物等として用いることができる。粉砕物としては、乾燥粉末、細片化物及びその乾燥物(乾燥細片化物)等が挙げられる。搾汁や抽出物は、液状であってもよいが、ペースト状や乾燥粉末(搾汁末、エキス末)として用いることもできる。抽出物は、適当な溶媒を用いて抽出することにより得ることができ、溶媒としては、例えば、水(熱水)、エタノール、含水エタノールを用いることができる。本発明においては、桑の乾燥粉末が好ましく、ケールと組み合わせることで、特に優れた筋芽細胞の増殖作用を発揮することから、桑の乾燥緑葉を粉砕し粉末化した乾燥粉末を用いることがより好ましい。また、ケールと組み合わせることで、特に優れた分散性向上作用を発揮することから、桑の乾燥粉末は、粒径75μm以下のものが60%以上であることが好ましく、75%以上であることがより好ましく、90%以上であることが特に好ましい。
(mulberry)
Mulberry is a plant of the Moraceae family. The site used in the present invention is preferably a leaf, and among leaves, green leaves are preferred. Moreover, the stem may be included together with the leaves. Mulberry can be used as a crushed product, squeezed juice, extract, etc. Examples of the pulverized product include a dry powder, a finely divided product, and a dried product thereof (dried finely divided product). The squeezed juice or extract may be in liquid form, but it can also be used in the form of a paste or dry powder (squeezed juice powder, extract powder). The extract can be obtained by extraction using an appropriate solvent, and examples of the solvent that can be used include water (hot water), ethanol, and aqueous ethanol. In the present invention, dry powder of mulberry is preferable, and since it exhibits a particularly excellent proliferative effect on myoblasts when combined with kale, it is more preferable to use dry powder obtained by crushing dry green leaves of mulberry. preferable. In addition, when combined with kale, it exhibits a particularly excellent dispersibility improving effect, so it is preferable that 60% or more of the dry mulberry powder has a particle size of 75 μm or less, and preferably 75% or more. More preferably, it is particularly preferably 90% or more.
(クマザサ)
クマザサ(熊笹)は、イネ科植物である。本発明において用いる部位としては、葉が好ましく、葉の中でも緑葉が好ましい。また、葉と共に茎を含んでいてもよい。クマザサは、粉砕物、搾汁、抽出物等として用いることができる。粉砕物としては、乾燥粉末、細片化物及びその乾燥物(乾燥細片化物)等が挙げられる。搾汁や抽出物は、液状であってもよいが、ペースト状や乾燥粉末(搾汁末、エキス末)として用いることもできる。抽出物は、適当な溶媒を用いて抽出することにより得ることができ、溶媒としては、例えば、水(熱水)、エタノール、含水エタノールを用いることができる。本発明においては、クマザサの乾燥粉末が好ましく、ケールと組み合わせることで、特に優れた筋芽細胞の増殖作用を発揮することから、クマザサの乾燥緑葉を粉砕し粉末化した乾燥粉末を用いることがより好ましい。また、ケールと組み合わせることで、特に優れた分散性向上作用を発揮することから、クマザサの乾燥粉末は、350メッシュ以下のものが50%以上であることが好ましく、75%以上であることがより好ましく、90%以上であることが特に好ましい。
(Kumazasa)
Kumazasa is a plant belonging to the Poaceae family. The site used in the present invention is preferably a leaf, and among leaves, green leaves are preferred. Moreover, the stem may be included together with the leaves. Kumazasa can be used as a crushed product, squeezed juice, extract, etc. Examples of the pulverized product include a dry powder, a finely divided product, and a dried product thereof (dried finely divided product). The squeezed juice or extract may be in liquid form, but it can also be used in the form of a paste or dry powder (squeezed juice powder, extract powder). The extract can be obtained by extraction using an appropriate solvent, and examples of the solvent that can be used include water (hot water), ethanol, and aqueous ethanol. In the present invention, dry powder of Kumzasa is preferable, and since it exhibits a particularly excellent myoblast proliferation effect when combined with kale, it is more preferable to use a dry powder obtained by crushing and powdering the dried green leaves of Kumzasa. preferable. In addition, when combined with kale, it exhibits a particularly excellent dispersibility-improving effect, so it is preferable that the dry powder of Kumazasa has 50% or more of 350 mesh or less, and more preferably 75% or more. Preferably, it is particularly preferably 90% or more.
本発明の経口組成物は、一般的な食品、食品添加剤、飼料等の他、優れた筋芽細胞の増殖作用に基づくダイエット(抗肥満)効果を有することから、例えば、特定保健用食品、栄養機能食品、機能性表示食品等の所定機関より効能の表示が認められた機能性食品などのいわゆる健康食品や、医薬品(医薬部外品を含む)として用いることができる。 In addition to general foods, food additives, feeds, etc., the oral composition of the present invention has a dieting (anti-obesity) effect based on the excellent myoblast proliferation effect, so it can be used, for example, as a food for specified health uses, It can be used as a so-called health food such as a functional food whose efficacy has been approved by a designated organization such as a nutritionally functional food or a food with functional claims, or as a medicine (including quasi-drugs).
すなわち、本発明の経口組成物は、いわゆる健康食品や医薬品等のダイエットのために用いられるダイエット用経口組成物として用いることができ、かかるダイエット用経口組成物としては、ケール及び所定の素材(他素材)を含有し、ダイエットに用いられる点において、製品として他の製品と区別することができるものであれば特に制限されるものではなく、例えば、本発明に係る製品の本体、包装、説明書、宣伝物のいずれかに、ダイエット機能がある旨を表示したものが本発明の範囲に含まれる。なお、本発明のダイエット用経口組成物は、製品の包装等に、本発明における組合せの成分(ケール及び他素材)がダイエットの有効成分として表示されているものに限られない。例えば、有効成分を特定していないものであってもよく、ケールのみを有効成分として表示したものであってもよい。 That is, the oral composition of the present invention can be used as a dieting oral composition used for dieting so-called health foods, medicines, etc.; The product is not particularly limited as long as it contains the following ingredients and can be distinguished from other products in that it can be used for dieting; for example, the main body, packaging, and instructions of the product according to the present invention. The scope of the present invention includes advertising materials that display the fact that they have a diet function. Note that the oral composition for dieting of the present invention is not limited to one in which the combined ingredients (kale and other ingredients) of the present invention are indicated as active ingredients for dieting on the product packaging or the like. For example, the active ingredient may not be specified, or only kale may be displayed as the active ingredient.
具体的に、いわゆる健康食品においては、「体重が気になる方へ」、「代謝を高める」、「肥満気味の方の体脂肪を減らすことを助ける」、「脂肪を代謝する力を高める」、「スタイルをサポート」等を表示したものを例示することができる。 Specifically, so-called health foods are ``for people who are concerned about their weight,'' ``increase metabolism,'' ``helping obese people reduce body fat,'' and ``increasing the ability to metabolize fat.'' , "Supports styles", etc. can be exemplified.
本発明の組成物の形態としては、例えば、錠状、カプセル状、粉末状、顆粒状、液状、粒状、棒状、板状、ブロック状、固形状、丸状、ペースト状、クリーム状、カプレット状、ゲル状、チュアブル状、スティック状等を挙げることができる。これらの中でも、錠状、カプセル状、粉末状、顆粒状、液状の形態が特に好ましい。具体的には、サプリメントや、ペットボトル、缶、瓶等に充填された容器詰飲料や、水(湯)、牛乳、果汁、青汁等に溶解して飲むためのインスタント飲料(粉末飲料)や、食品添加剤を例示することができる。これらは食事の際などに手軽に飲用しやすく、また嗜好性を高めることができるという点で好ましい。 Examples of the form of the composition of the present invention include tablets, capsules, powders, granules, liquids, granules, rods, plates, blocks, solids, rounds, pastes, creams, and caplets. , gel form, chewable form, stick form, etc. Among these, tablet, capsule, powder, granule, and liquid forms are particularly preferred. Specifically, these include supplements, packaged beverages filled in plastic bottles, cans, bottles, etc., instant beverages (powdered beverages) that can be dissolved in water (hot water), milk, fruit juice, green juice, etc. , food additives can be exemplified. These are preferable because they are easy to drink during meals and can enhance palatability.
本発明の経口組成物におけるケール及び他素材(本発明の成分)の含有量としては、その効果の奏する範囲で適宜含有させればよい。 The content of kale and other materials (components of the present invention) in the oral composition of the present invention may be appropriately contained within the range where their effects are achieved.
一般的には、本発明の経口組成物が錠状、錠剤状等のサプリメントや医薬品の場合には、本発明の成分が乾燥質量換算で組成物全体の0.01~100質量%含まれていることが好ましく、0.1~80質量%含まれていることがより好ましく、1~60質量%含まれていることがさらに好ましい。 Generally, when the oral composition of the present invention is a supplement or medicine in tablet form, the ingredient of the present invention is contained in an amount of 0.01 to 100% by mass of the entire composition in terms of dry mass. The content is preferably from 0.1 to 80% by mass, and even more preferably from 1 to 60% by mass.
本発明の経口組成物が容器詰飲料である場合には、本発明の成分が組成物全体の0.001~30質量%含まれていることが好ましく、0.01~20質量%含まれていることがより好ましく、0.1~15質量%含まれていることがさらに好ましい。 When the oral composition of the present invention is a packaged beverage, the component of the present invention is preferably contained in an amount of 0.001 to 30% by mass, and preferably 0.01 to 20% by mass of the entire composition. It is more preferable that the content is 0.1 to 15% by mass.
また、本発明の経口組成物が青汁等のインスタント飲料である場合には、本発明の成分が乾燥質量換算で組成物全体の0.01~100質量%含まれていることが好ましく、0.1~80質量%含まれていることがより好ましく、1~60質量%含まれていることがさらに好ましい。 Furthermore, when the oral composition of the present invention is an instant beverage such as green juice, it is preferable that the component of the present invention is contained in an amount of 0.01 to 100% by mass of the entire composition in terms of dry mass; The content is more preferably 1 to 80% by mass, and even more preferably 1 to 60% by mass.
本発明の効果をより有効に発揮させるためには、本発明の成分が乾燥質量換算で本発明の経口組成物全体の70%以上含まれていることが好ましく、80%以上含まれていることがより好ましく、90%以上含まれていることがさらに好ましく、100%であることが特に好ましい。 In order to more effectively exhibit the effects of the present invention, it is preferable that the ingredients of the present invention are contained in an amount of 70% or more, and preferably 80% or more, of the entire oral composition of the present invention in terms of dry mass. It is more preferable that the content is 90% or more, and it is particularly preferable that the content is 100%.
本発明の経口組成物の摂取量としては特に制限はないが、本発明の効果をより顕著に発揮させる観点から、成人の1日当たり、ケール摂取量が乾燥質量換算で、0.01g/日以上となるように摂取することが好ましく、0.1g/日以上となるように摂取することがより好ましく、1g/日以上となるように摂取することがさらに好ましい。その上限は、例えば、30g/日であり、好ましくは20g/日であり、より好ましくは10g/日である。本発明の経口組成物は、1日の摂取量が前記摂取量となるように、1つの容器に、又は例えば2~3の複数の容器に分けて、1日分として収容することができる。 Although there is no particular restriction on the amount of oral composition of the present invention to be ingested, from the viewpoint of more significantly exerting the effects of the present invention, the daily intake of kale for adults is 0.01 g/day or more in terms of dry mass. It is preferable to take in an amount of 0.1 g/day or more, more preferably 0.1 g/day or more, and even more preferably 1 g/day or more. The upper limit is, for example, 30 g/day, preferably 20 g/day, and more preferably 10 g/day. The oral composition of the present invention can be stored in one container or divided into a plurality of containers, for example, 2 to 3, so that the daily intake amount is the above-mentioned intake amount.
ケール及び他素材の配合質量比としては、乾燥質量換算で、0.0001:1~10000:1であることが好ましく、0.001:1~1000:1であることがより好ましく、0.01:1~100:1であることがさらに好ましい。 The blending mass ratio of kale and other materials is preferably 0.0001:1 to 10000:1, more preferably 0.001:1 to 1000:1, and 0.01 in terms of dry mass. More preferably, the ratio is from 1 to 100:1.
本発明の経口組成物は、必要に応じて、本発明の成分以外の他の成分を添加して、公知の方法によって製造することができる。本発明の成分以外の他の成分としては、例えば、水溶性ビタミン(ビタミンB1、B2、B3、B5、B6、B12、B13、B15、B17、ビオチン、コリン、葉酸、イノシトール、PABA、ビタミンC、ビタミンP)、油溶性ビタミン(ビタミンA、D、E、K)等のビタミン類;カルシウム、マグネシウム、リン、鉄等のミネラル類;タウリン、ニンニク等に含まれる含硫化合物;ヘスペリジン、ケルセチン等のフラバノイド或いはフラボノイド類;コラーゲン等のタンパク質;ペプチド;アミノ酸;動物性油脂;植物性油脂;動物・(ケール及び本発明の他素材以外の)植物の粉砕物又は抽出物等を挙げることができる。 The oral composition of the present invention can be manufactured by a known method by adding other components other than the components of the present invention, if necessary. Other ingredients other than the ingredients of the present invention include, for example, water-soluble vitamins (vitamins B1, B2, B3, B5, B6, B12, B13, B15, B17, biotin, choline, folic acid, inositol, PABA, vitamin C, Vitamins such as vitamin P) and oil-soluble vitamins (vitamins A, D, E, K); Minerals such as calcium, magnesium, phosphorus, and iron; Sulfur-containing compounds contained in taurine, garlic, etc.; Hesperidin, quercetin, etc. Examples include flavanoids or flavonoids; proteins such as collagen; peptides; amino acids; animal fats and oils; vegetable fats and oils; ground products or extracts of animals and plants (other than kale and other materials of the present invention).
本発明の経口組成物は、後述する実施例で示された筋芽細胞の増殖促進作用を奏することにより、筋芽細胞増殖用組成物、筋肉増強用組成物、筋量増加用組成物、エネルギー代謝活性化剤、ダイエット用組成物、脂肪組織低減用組成物、体脂肪低減用組成物として優れたものとなりうる。また、後述する実施例で示された分散性向上の作用を奏することにより、凝集しにくく分散性の高い、経口組成物として優れたものとなりうる。 The oral composition of the present invention has the effect of promoting the proliferation of myoblasts as shown in the Examples described below, and thus can be used as a composition for myoblast proliferation, a composition for muscle strengthening, a composition for increasing muscle mass, and a composition for increasing muscle mass. It can be excellent as a metabolic activator, a composition for dieting, a composition for reducing adipose tissue, and a composition for reducing body fat. Furthermore, by exhibiting the effect of improving dispersibility as shown in the Examples described later, it can be made into an excellent oral composition that is resistant to agglomeration and has high dispersibility.
以下、実施例に基づき、本発明を説明する。
[実施例1]
(原料)
ケールとしては、ケールの葉を乾燥して粉末化したケール乾燥粉末(粒径75μm以下が90%以上;東洋新薬社製)を用いた。
クマザサとしては、クマザサの葉を乾燥して粉末化したクマザサ乾燥粉末(350メッシュ以下が90%以上;市販品)を用いた。
桑葉としては、乾燥した桑の葉を、粉末化した桑葉乾燥粉末(粒径75μm以下が90%以上;東洋新薬社製)を用いた。
プロテインとしては、脱脂大豆から抽出した豆乳を酸沈して得られるカードを中和後、乾燥して20メッシュの篩にかけて得られる粉末状分離大豆タンパク(乾物換算でタンパク質含量90%以上;市販品)を用いた。
ギムネマとしては、ギムネマ・シルベスタの葉を含水エタノールで抽出し、その抽出物を乾燥して粉末化したギムネマ・シルベスタ末(エキス末;40メッシュ以下が90%以上、80メッシュ以下が85%以上、ギムネマ酸含量25~30%;市販品)を用いた。 スクラロースとしては、粉末状のスクラロースを20メッシュの篩にかけて得られたスクラロース粉末(市販品)を用いた。
The present invention will be explained below based on Examples.
[Example 1]
(material)
As the kale, dried kale powder (90% or more having a particle size of 75 μm or less; manufactured by Toyo Shinyaku Co., Ltd.) obtained by drying and pulverizing kale leaves was used.
As the Kumzaza, Kumzaza dry powder (90% or more of Kumzaza of 350 mesh or less; commercially available), which was obtained by drying and powdering Kumzaza leaves, was used.
As the mulberry leaves, dry mulberry leaf powder (90% or more of particles having a particle size of 75 μm or less; manufactured by Toyo Shinyaku Co., Ltd.) was used.
As protein, we use powdered isolated soy protein (protein content of 90% or more on dry matter basis; commercially available product) obtained by neutralizing the curd obtained by acid precipitation of soy milk extracted from defatted soybeans, then drying and passing through a 20-mesh sieve. ) was used.
As gymnema, Gymnema sylvestre leaves are extracted with aqueous ethanol, and the extract is dried and powdered. Gymnemic acid content 25-30%; commercially available product) was used. As the sucralose, sucralose powder (commercially available) obtained by passing powdered sucralose through a 20 mesh sieve was used.
これらを表1に示す被験物質濃度(μg/mL)及び表2に示す配合割合にて原料を配合し、各試験を実施した。 These were mixed with raw materials at the test substance concentrations (μg/mL) shown in Table 1 and the mixing ratios shown in Table 2, and each test was conducted.
[試験例1]
(細胞増殖試験)
37℃、5%CO2インキュベーター内で、75cm2フラスコを用いて、マウス筋芽細胞(C2C12)を10%FBS-DMEMにより培養した。トリプシン処理により浮遊させた細胞を、75cm2フラスコからコラーゲンコートした96ウェルプレートの各ウェルに1ウェルあたり細胞数が8000となる細胞密度で播種した。
[Test Example 1]
(Cell proliferation test)
Mouse myoblasts (C2C12) were cultured with 10% FBS-DMEM in a 75
37℃、5%CO2インキュベーターで24時間前培養後、10%FBS-DMEMで調製した被験物質を100μLウェルに添加した。
具体的に、被験物質の調製及び添加は、以下のように行った。
まず、被験物質が5mg/mlとなるように10%FBS-DMEMに懸濁させ、0.2μmのフィルターでろ過した。次いで、この被験物質が5mg/mlの懸濁液を、さらに10%FBS-DMEMで希釈し、表1に示す濃度となるようウェルに添加した。
After preincubation for 24 hours at 37°C in a 5% CO2 incubator, 100 μL of the test substance prepared in 10% FBS-DMEM was added to the wells.
Specifically, the test substance was prepared and added as follows.
First, the test substance was suspended in 10% FBS-DMEM to a concentration of 5 mg/ml, and filtered through a 0.2 μm filter. Next, this test substance suspension containing 5 mg/ml was further diluted with 10% FBS-DMEM and added to the wells to give the concentrations shown in Table 1.
24時間培養後、PBSで2回洗浄しフィルター滅菌したMTT溶液(MTT500μg/ml in DMEM)を100μL添加し、さらに3時間培養した。PBSで2回洗浄し、0.04HCl in イソプロパノールを100μL添加した。 After culturing for 24 hours, 100 μL of MTT solution (MTT 500 μg/ml in DMEM), which had been washed twice with PBS and filter sterilized, was added and cultured for an additional 3 hours. After washing twice with PBS, 100 μL of 0.04 HCl in isopropanol was added.
色素が細胞外に溶出したのを確認し、吸光度(570nm、630nm)を測定し、細胞増殖率(% of control)を求めた。 After confirming that the dye had eluted out of the cells, the absorbance (570 nm, 630 nm) was measured to determine the cell proliferation rate (% of control).
% of control =[SampleDate]/[ControlDate]×100 % of control = [SampleDate] / [ControlDate] x 100
Data =[(Sample570nm-Sample630nm)-(blank570nm-blank630nm)] Data = [(Sample570nm-Sample630nm)-(blank570nm-blank630nm)]
Sample570nm、blank570nmは、570nmにおける吸光度の値であり、Sample630nm、blank630nmは、630nm(濁度)における吸光度の値である。 Sample570nm and blank570nm are absorbance values at 570 nm, and Sample630nm and blank630nm are absorbance values at 630 nm (turbidity).
その結果を表1に示す。 The results are shown in Table 1.
表1に示すように、ケールと共に少なくとも1種以上の他素材を配合した本発明の組成物は、単独で配合した場合から想定される理論値(比較例の値を用いて配合比率を元に計算した値)よりも細胞増殖率の増加がみられた。すなわち、ケールと他素材の組合せによる相乗的な増加がみられた。特に、ケールと共に2種の他素材を配合した場合は、1種の他素材を配合した場合と比較してもその増加は顕著であり、中でも、ケール、桑及びプロテインを含む実施例7、ケール、ギムネマ及びスクラロースを含む実施例8では、特に顕著な増加がみられ、優れたダイエット効果が期待できる。 As shown in Table 1, the composition of the present invention, which contains at least one other material together with kale, has a theoretical value (based on the blending ratio using the value of the comparative example) that would be expected if kale was blended alone. An increase in the cell proliferation rate was observed compared to the calculated value). In other words, a synergistic increase was observed due to the combination of kale and other ingredients. In particular, when two types of other materials are blended together with kale, the increase is remarkable compared to when one type of other material is blended, and among them, Example 7 containing kale, mulberry and protein, kale In Example 8 containing , gymnema, and sucralose, a particularly remarkable increase was observed, and an excellent dieting effect can be expected.
[試験例2]
(分散性試験)
各原料を篩(呼び寸法:710)にかけた。2原料以上を組み合わせる場合は表2の割合に従って分散度を測定するために必要な量を計りとり、均一になるまで手で振ってビニール袋内で混合した。
[Test Example 2]
(Dispersibility test)
Each raw material was passed through a sieve (nominal size: 710). When two or more raw materials were combined, the amount required for measuring the degree of dispersion was measured according to the proportions shown in Table 2, and mixed by hand in a plastic bag until uniform.
被験物質10gを計りとり、ホソカワミクロン社製の粉体特定評価装置「パウダテスタPT-X」を用いて分散度を測定した。分散度の測定は当該機器のマニュアルに従って行った。 10 g of the test substance was weighed out, and the degree of dispersion was measured using a powder specific evaluation device "Powder Tester PT-X" manufactured by Hosokawa Micron. The degree of dispersion was measured according to the manual of the device.
なお、分散度は以下のような方法によって測定される。
規定重量(W)の試料を規定の高さから受け皿に落下させて、受け皿に乗った試料の重量(W1)を測定する。さらに、次の式によって、分散度を算出する。
Note that the degree of dispersion is measured by the following method.
A sample with a specified weight (W) is dropped from a specified height onto a receiving tray, and the weight (W1) of the sample on the receiving tray is measured. Furthermore, the degree of dispersion is calculated using the following formula.
分散度(%)=(W-W1)/W×100 Dispersity (%) = (W-W1)/W x 100
各被験物質の構成及びその結果を表2及び図1~5に示す。 The composition and results of each test substance are shown in Table 2 and Figures 1 to 5.
表2に示すように、ケールと共に他素材を配合した本発明の組成物は、ケール単独に比して、いずれも分散度が高く、分散性が向上した。また、各素材を単独で配合した場合から想定される分散度の理論値(比較例の値を用いて配合比率を元に計算した値)よりも分散度が高く、分散性が向上した。 As shown in Table 2, the compositions of the present invention containing kale and other materials had a higher degree of dispersion and improved dispersibility than kale alone. In addition, the dispersion was higher than the theoretical value of the dispersion (value calculated based on the blending ratio using the value of the comparative example) that would be expected if each material was blended alone, and the dispersibility was improved.
図1に示すように、ケールとクマザサにさらにクマザサ以外の他素材のいずれかを配合した本発明の組成物は、ケールとクマザサにさらにギムネマを配合した3種類の組合せ(実施例14)において、ケールとクマザサを配合した2種類の組合せ(実施例9)よりも、顕著な分散性の向上がみられた。ケールとクマザサにさらに桑葉、プロテイン、スクラロースからから選ばれる1つの他素材を配合した3種類の組合せ(実施例17、18、19)は、ケールとクマザサの2種類の組合せよりも分散性は低くなったものの、理想値よりも分散性の向上がみられた。 As shown in FIG. 1, the composition of the present invention in which kale and kumazaa are further blended with any other material other than kumazasa has three types of combinations (Example 14) in which kale and kumazaa are further blended with gymnema. A remarkable improvement in dispersibility was observed compared to the two types of combination (Example 9) in which kale and kumazana were blended. The three types of combinations (Examples 17, 18, and 19) in which kale and black lettuce were combined with one other material selected from mulberry leaves, protein, and sucralose had better dispersibility than the two combinations of kale and black lettuce. Although the value was lower, the dispersibility was improved compared to the ideal value.
図2に示すように、ケールと桑葉にさらに桑葉以外の他素材のいずれかを配合した本発明の組成物(実施例15、17、20、21)は、ケールと桑葉を配合した2種類の組合せ(実施例10)よりも、顕著な分散性の向上がみられた。 As shown in Figure 2, the compositions of the present invention (Examples 15, 17, 20, and 21) in which kale and mulberry leaves were further blended with any other material other than mulberry leaves were mixed with kale and mulberry leaves. A remarkable improvement in dispersibility was observed compared to the combination of the two types (Example 10).
図3に示すように、ケールとプロテインにさらにプロテイン以外の他素材のいずれかを配合した本発明の組成物は、ケールとプロテインを配合した2種類の組合せ(実施例11)よりも、ケールとプロテインにさらに桑葉、クマザサ、スクラロースから選ばれる1つの他素材を配合した3種類の組合せ(実施例15、18、23)において、顕著な分散性の向上がみられた。ケール、プロテインとギムネマを配合した3種類の組合せ(実施例22)は、ケールとプロテインを配合した2種類の組合せ(実施例11)と同程度の分散性であったものの、理想値よりも分散性の向上がみられた。 As shown in Figure 3, the composition of the present invention in which kale and protein are further blended with any other material other than protein is more effective than the two combinations containing kale and protein (Example 11). A remarkable improvement in dispersibility was observed in three combinations (Examples 15, 18, and 23) in which protein was further blended with one other material selected from mulberry leaf, kumazase, and sucralose. The three combinations of kale, protein, and gymnema (Example 22) had the same level of dispersibility as the two combinations of kale and protein (Example 11), but the dispersion was lower than the ideal value. There was an improvement in sexual performance.
図4に示すように、ケールとギムネマにさらにギムネマ以外の他素材のいずれかを配合した本発明の組成物は、ケールとギムネマにさらにクマザサを配合した3種類の組合せ(実施例14)は、ケールとギムネマを配合した2種類の組合せ(実施例12)よりもさらに分散性の向上がみられた。ケールとギムネマにさらにスクラロース、桑葉、プロテインから選ばれる1つの他素材を配合した本発明の組成物(実施例16、20、22)は、ケールとギムネマを配合した2種類組合せ(実施例12)よりも、分散性は低くなったものの、理想値よりも分散性の向上がみられた。 As shown in FIG. 4, the composition of the present invention is one in which kale and gymnema are further blended with any other material other than gymnema; Further improvement in dispersibility was observed compared to the two combinations of kale and gymnema (Example 12). The compositions of the present invention (Examples 16, 20, and 22) in which kale and gymnema are further blended with one other material selected from sucralose, mulberry leaves, and protein are two types of compositions (Example 12) in which kale and gymnema are blended. ), the dispersibility was lower than the ideal value, but the dispersibility was improved compared to the ideal value.
図5に示すように、ケールとスクラロースにさらにスクラロース以外の他素材のいずれかを配合した本発明の組成物(実施例16、19、21、23)は、ケールとスクラロースを配合した2種類の組合せ(実施例13)よりも、顕著な分散性の向上がみられた。 As shown in Figure 5, the compositions of the present invention (Examples 16, 19, 21, 23) in which kale and sucralose are further blended with any other material other than sucralose are different from the two types in which kale and sucralose are blended. A remarkable improvement in dispersibility was observed compared to the combination (Example 13).
以上のことから、本発明の組成物は、ケールと共に他素材を単に混合するだけで、分散性の高い組成物が得られており、原料の処理、混合時の給気などの煩雑な操作を必要としないものであることがわかる。 From the above, the composition of the present invention can be obtained by simply mixing other materials with kale, and can be obtained without complicated operations such as processing raw materials and supplying air during mixing. Turns out it's not needed.
[配合例]
表3に示す粉末状の飲食用組成物(本発明の経口組成物)を調製した。得られた本発明の組成物3gを150mLの水と混合し、飲用したところ、ケールの臭いや味が改善され、総合的な嗜好性に優れた飲料が得られた。
[Formulation example]
A powdered edible composition (oral composition of the present invention) shown in Table 3 was prepared. When 3 g of the resulting composition of the present invention was mixed with 150 mL of water and drunk, a beverage with improved kale odor and taste and excellent overall palatability was obtained.
本発明の経口組成物は、いわゆる健康食品等として用いることができることから、産業上有用である。 The oral composition of the present invention is industrially useful because it can be used as a so-called health food.
Claims (1)
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2019193034A JP7385256B2 (en) | 2018-09-28 | 2019-10-23 | Oral composition |
JP2021115227A JP2021166544A (en) | 2019-10-23 | 2021-07-12 | Oral composition |
JP2022071950A JP2022095986A (en) | 2019-10-23 | 2022-04-25 | Oral composition |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2018185732A JP6620323B1 (en) | 2018-09-28 | 2018-09-28 | Oral composition |
JP2019193034A JP7385256B2 (en) | 2018-09-28 | 2019-10-23 | Oral composition |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2018185732A Division JP6620323B1 (en) | 2018-09-28 | 2018-09-28 | Oral composition |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2021115227A Division JP2021166544A (en) | 2019-10-23 | 2021-07-12 | Oral composition |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2020074765A JP2020074765A (en) | 2020-05-21 |
JP7385256B2 true JP7385256B2 (en) | 2023-11-22 |
Family
ID=88833413
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2019193034A Active JP7385256B2 (en) | 2018-09-28 | 2019-10-23 | Oral composition |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP7385256B2 (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100415765B1 (en) | 2002-01-21 | 2004-01-24 | 주식회사 체리부로 | A chicken processed foodstuffs containing the powder of mulberry leaves |
JP2004269395A (en) | 2003-03-07 | 2004-09-30 | Minato Pharmaceutical Co Ltd | Hypotensive action-having composition |
JP2004357584A (en) | 2003-06-04 | 2004-12-24 | Minato Pharmaceutical Co Ltd | Composition with masked unpleasant odor |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002204671A (en) * | 2001-01-11 | 2002-07-23 | Toyo Shinyaku:Kk | Antihypertensive food containing kale processed product |
JP3769274B2 (en) * | 2003-08-29 | 2006-04-19 | 日本製粉株式会社 | Green leaf granule and method for producing green leaf granule |
JP2006166776A (en) * | 2004-12-15 | 2006-06-29 | Nippon Flour Mills Co Ltd | Beverage, granulated product, and method for producing the granulated product |
JP2006204145A (en) * | 2005-01-26 | 2006-08-10 | Hokurin:Kk | Emulsified protein derived from soybean, and beverage obtained by diluting the protein |
JP6364288B2 (en) * | 2014-09-04 | 2018-07-25 | 株式会社日清製粉グループ本社 | Non-dry or semi-dry small pasta with dietary fiber |
JP2018080148A (en) * | 2016-11-18 | 2018-05-24 | 株式会社東洋新薬 | Composition for preventing and/or improving climacteric symptom |
-
2019
- 2019-10-23 JP JP2019193034A patent/JP7385256B2/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100415765B1 (en) | 2002-01-21 | 2004-01-24 | 주식회사 체리부로 | A chicken processed foodstuffs containing the powder of mulberry leaves |
JP2004269395A (en) | 2003-03-07 | 2004-09-30 | Minato Pharmaceutical Co Ltd | Hypotensive action-having composition |
JP2004357584A (en) | 2003-06-04 | 2004-12-24 | Minato Pharmaceutical Co Ltd | Composition with masked unpleasant odor |
Non-Patent Citations (10)
Title |
---|
Amazon,GRON プロテインブレンドグリーンモンスター 227g(PTOTEIN BLEND GreenMonster),[online],Amazon.co.jpでの取り扱い開始日:2019/711,[検索日:2021/6/4],<URL:https://%E3%83%97%E3%83%AD%E3%83%86%E3%82%A4%E3%83%B3%E3%83%96%E3%83%AC%E3%83%B3%E3%83%89-%E3%82%B0%E3%83%AA%E3%83%BC%E3%83%B3%E3%83%A2%E3%83%B3%E3%82%B9%E3%82%BF%E3%83%BC-227G%EF%BC%88PROTEIN-BLEND-MOnStER%EF%BC%89%E3%80%90%E6%A4%8D%E7%89%A9%E6%80%A7%E3%82%BD%E3%82%A4%E3%83%97%E3%83%AD%E3%83%86%E3%82%A4%E3%83%B3%E3%80%91/DP/B07TQJPJCS> |
Amazon,MyProtein マイプロテイン Impact ホエイプロテイン 1kg(限定フレーバー)ミルクティー,[online],Amazon.co.jpでの取り扱い開始日:2018/3/6,<URL:https://amazon.co.jp/%E3%83%9E%E3%82%A4%E3%83%97%E3%83%AD%E3%83%86%E3%82%A4%E3%83%B3IMPACt-%E3%83%9B%E3%82%A8%E3%82%A4%E3%83%97%E3%83%AD%E3%83%86%E3%82%A4%E3%83%B3-%E9%99%90%E5%AE%9A%E3%83%95%E3%83%AC%E3%83%BC%E3%83%90%E3%83%BC-%E3%83%9F%E3%83%AB%E3%82%AF%E3%83%86%E3%82%A3%E3%83%BC/DP/B07B8BVT8K/REF=PsDC_169976011_t1_B00I95ZWA6> |
Amazon,ザバス(SAVAS) アクアホエイプロテイン100+クエン酸 グレープフルーツ風味[40食分]840g,[online],Amazon.cp.jpでの取り扱い開始日:2014/2/3,[検索日:2021/6/4],<URL:https://www.amason.co.jp/%E3%82%B6%E3%83%90%E3%82%B9-SAVAS-%E3%82%A2%E3%82%AF%E3%82%A2%E3%83%9B%E3%82%A8%E3%82%A4%E3%83%97%E3%83%AD%E3%83%86%E3%82%A4%E3%83%B3100-%E3%82%AF%E3%82%A8%E3%83%B3%E9%85%B8-%E3%82%B0%E3%83%AC%E3%83%BC%E3%83%97%E3%83%95%E3%83%AB%E3%83%BC%E3%83%84%E9%A2%A8%E5%91%B3%E3%80%9040%E9%A3%9F%E5%88%86%E3%80%91/DP/B00IEA4OSW/REF=SR_1_2?__MK_JA_JP=%E3%82%AB%E3%82%BF%E3%82%AB%E3%83%8A&DCHILD=1&KEywORDS=%E3%83%97%E3%83%AD%E3%83%86%E3%82%A4%E3%83%B3+%E6%A1%91%E3%81%AE%E8%91%89&QID=1622767421&S=HPC&SR=1-2> |
Amazon,ビーレジェンド ホエイプロテイン ペコちゃん ミルキー風味1kg,[online],Amazon.co.jpでの取り扱い開始日:2018/1/29,[検索日:2021/6/4],<URL:https://amazon.co.jp//DP/B079FKCQS6/REF=Syn_SD_OnSItE_DESKtOP_161?PSC=1&uH_It=051845C5CA155ED68FE1F0C4EB9960E1_CT&SPLA=ZW5JCnLwDGVKUXVHBGLMAWVyPUEyN1I2VZJPOTZHWDNNJMVuY3J5CHRLZELKPUEwODEXNDAXMTG4OVFMNEMwN1LHQIZLBMNyEXB0ZWRBZELKPUEZTE1HU1PUQZC2MFI1JnDPZGDLDE5HBWU9C2RFB25ZAXRLX2RLC2t0B3AMYWN0AW9uPWNSAWNRUMVKAXJLY3QMZG9OB3RMB2DDBGLJAZ10CnVL> |
Amazon,ビーレジェンド ホエイプロテイン ベリベリベリー風味 1kg,[online],Amazon.co.jpでの取り扱い開始日:2016/5/17,[検索日:2021/6/4],<URL:https://www.amazon.cp.jp/%E3%83%93%E3%83%BC%E3%83%AC%E3%82%B8%E3%82%A7%E3%83%B3%E3%83%89-BE-LEGEND-%E3%83%9B%E3%82%A8%E3%82%A4%E3%83%97%E3%83%AD%E3%83%86%E3%82%A4%E3%83%B3-%E3%83%99%E3%83%AA%E3%83%99%E3%83%AA%E3%83%99%E3%83%AA%E3%83%BC%E9%A2%A8%E5%91%B3/DP/B01FRT7D4E/REF=PSDC_169976011_t3_B079FKCQS6> |
Amazon,ファイン・ラボ ホエイプロテインピュアアイソレート ミルクココア風味,[online],Amazon.co.jpでの取り扱い開始日:2007/7/5,[検索日2021/06/04],<URL:https://www.amazon.cp.jp/%E3%83%95%E3%82%A1%E3%82%A4%E3%83%B3%E3%83%BB%E3%83%A9%E3%83%9C-%E3%83%9B%E3%82%A8%E3%82%A4%E3%83%97%E3%83%AD%E3%83%86%E3%82%A4%E3%83%B3%E3%83%94%E3%83%A5%E3%82%A2%E3%82%A2%E3%82%A4%E3%82%BD%E3%83%AC%E3%83%BC%E3%83%88-%E3%83%97%E3%83%AC%E3%83%BC%E3%83%B3%E9%A2%A8%E5%91%B3-1kg/dp/B000T1E588?th=1> |
ミナトヘルスフーズ,micoco玄米プロテイン,[online],Amazon.co.jpでの取り扱い開始日:2014/2/3,[検索日:2021/6/4],<URL:https://web.archive.org/web/20180901000148/https://minatoshiki.com/syouhin/micoco_protein.html> |
やわたのおいしい青汁(約1ヶ月分 30袋入),[online],2017年7月2日,[検索日:2023/6/2],<URL:https://www.yawata.tv/p/313665> |
国産青汁粒,[online],2009年11月29日,[検索日:2023/6/2],<URL:https://www.inship.jp/article/0310.html> |
有機サプリメント 青汁100%,[onine],2017年8月18日,[検索日:2023/6/2,<URL:https://item.rakuten.co.jp/collagenkirei/yukiaotubu-01/> |
Also Published As
Publication number | Publication date |
---|---|
JP2020074765A (en) | 2020-05-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2024009190A (en) | Bone fortifier dietary supplements | |
JP2022031912A (en) | Oral composition | |
JP2023108043A (en) | oral composition | |
JP2019034896A (en) | Oral composition | |
JP7385256B2 (en) | Oral composition | |
JP2007037525A (en) | Health food | |
JP6753618B2 (en) | Composition for suppressing increase in triglyceride in blood | |
JP6620323B1 (en) | Oral composition | |
JP6841444B2 (en) | Immunostimulant | |
JP2020186264A (en) | In-blood neutral fat increase inhibitory composition | |
JP7401082B2 (en) | Oral composition | |
JP6541047B1 (en) | Oral composition | |
JP2017002009A (en) | Adjuvant | |
JP2022095986A (en) | Oral composition | |
JP7122727B2 (en) | Beverage containing ferulic acid | |
JP7290383B2 (en) | oral composition | |
JP7248272B2 (en) | oral composition | |
JP6829487B2 (en) | Anti-fatigue | |
JP6838752B2 (en) | Blood flow improving composition | |
JP6956938B2 (en) | Foods for suppressing the rise of triglycerides in blood | |
JP6515257B1 (en) | Composition for eating and drinking | |
JP7117763B2 (en) | oral composition | |
JP7228184B2 (en) | Eating and drinking composition | |
JP2022173468A (en) | Bloodstream ameliorating composition | |
JP2023099752A (en) | oral composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20210422 |
|
A871 | Explanation of circumstances concerning accelerated examination |
Free format text: JAPANESE INTERMEDIATE CODE: A871 Effective date: 20210422 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20210628 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20210820 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20211018 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20211210 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20220214 |
|
C60 | Trial request (containing other claim documents, opposition documents) |
Free format text: JAPANESE INTERMEDIATE CODE: C60 Effective date: 20220407 |
|
C22 | Notice of designation (change) of administrative judge |
Free format text: JAPANESE INTERMEDIATE CODE: C22 Effective date: 20230213 |
|
C22 | Notice of designation (change) of administrative judge |
Free format text: JAPANESE INTERMEDIATE CODE: C22 Effective date: 20230410 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20230906 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20231102 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 7385256 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |